Greeks, Italians and Spanish people have been smoking and drinking more than anyone else for centuries, but still live longer than the rest of us – because of lycopene.
The problem for scientists until now, has been finding a way of ensuring that lycopene is reliably absorbed. Now a team of Cambridge scientists have come up with Ateronon, a new lycopene compound which can be taken as a one pill a day treatment, which instantly raises blood lycopene to the optimum level.

The first data on this new wonder treatment were presented at the World congress on heart disease in Toronto last year (2008), http://www.cardiologyonline.com/wchd08/advance_program.htm

The study ATERONON: FIRST CLINICALLY PROVEN ANTI-ATHEROGENIC ANTIOXIDANT
makes interesting reading. It claims to have completed eliminated the low density lipoprotein oxidation that leads to the build up of atherosclerosis.

Another study by ATERONON, CHLAMYDIA INFECTION IN CARDIOVASCULAR PATHOLOGY: SEQUEL II from the same Ateronon inventors, showed how chlamydia pneumoniae, a bacterial infection, seems to be involved in the development of clogged arteries. People with the condition always seem to have the bacteria in their bodies. Cambridge Theranostics, the team who have invented Ateronon, has also developed a blood test for the antibodies to chlamydia pneumoniae. This tells you whether active atherosclerosis is going on, or whether the tomato pill is effectively damping down the disease process.

It is a simple, but clever way of finding out how well Ateronon is doing. There is a lot of interest in Ateronon from researchers investigating heart and circulatory disease, and projects have just got underway at Harvard medical school in America and Cambridge university in Britain, to monitor the future health of sick people taking Ateronon long term.